JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB64211

Antibody Diluent

5

(1 Review)

|

(17 Publications)

Antibody Diluent (ab64211) is used to dilute monoclonal and polyclonal primary antibodies and secondary antibodies to their working concentrations for use in immunohistochemistry (IHC).

- Supplied as ready-to-use reagent
- Contains a highly purified carrier protein that minimizes proteolytic enzyme degradation
- Compatible with our Lab essentials imaging workflow offering.
- Cited in over 15 publications

Key facts

Applications

IHC-P

applications

Target

Antibody Diluent

target

Form

Liquid

form

Storage buffer

pH: 7 - 7.8 Preservative: 0.05% Sodium azide

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Antibody Diluent ab64211 is used to dilute primary antibodies to their working concentrations for use in IHC. It can also be used for convenient storage of diluted primary antibodies.

The antibody diluent is formulated to reduce background and non-specific binding of the primary antibody. In most cases, antibodies can be stored in the diluent, at their working concentrations for IHC, for up to 24 months at 2-8°C.

The diluent is based on a Tris buffer, and contains a stabilizing carrier protein, a wetting agent to reduce surface tension, an anti-microbial agent, and a green dye. It should not be used with HRP-conjugated primary antibodies.

IHC protocol suitable for use with Antibody Diluent ab64211:
For fluorescent IHC, skip step 3, incubate with fluorescent dye conjugated secondary at step 6, skip rest of steps, and mount with anti-fade mounting medium.

1. Deparaffinize and rehydrate formalin-fixed paraffin-embedded tissue section.

2. Use appropriate antigen retrieval buffer or enzyme (primary antibody dependent) to treat sections. Wash 3 times in buffer.

3. Add enough hydrogen peroxide blocking solution to cover the sections. Incubate for 10 minutes. Wash 2 times in buffer. If necessary, use avidin biotin blocking.

4. Apply protein block (or normal serum from same species as secondary antibody) and incubate for 5 minutes at room temperature to block nonspecific background staining. Wash once in buffer.

5. Apply primary antibody in Antibody Diluent ab64211 and incubate.

6. Wash 4 times in buffer. Incubate slide with biotinylated secondary antibody (or HRP polymer secondary antibody and skip step 7). Wash 4 times in buffer.

7. Apply streptavidin-HRP and incubate for 10 minutes at room temperature.

8. Rinse 4 times in buffer. Place slide in DAB substrate or AEC substrate and incubate until desired color is achieved (1-10 mins). Rinse 4 times in buffer.

9. Add enough drops of hematoxylin to cover the section. Incubate for 1 minute.

10. Rinse 7-8 times in tap water. Add mounting medium to cover the section.

Find complete IHC kits, and reagents for antigen retrieval, blocking, signal amplification, visualization, counterstaining, and mounting in the IHC kits and reagents guide.

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Orthopaedic journal of sports medicine 9:2325967121990377 PubMed33959667

2021

Platelet-Rich Plasma Releasate Promotes Early Healing in Tendon After Acute Injury.

Applications

Unspecified application

Species

Unspecified reactive species

Tung-Yang Yu,Jong-Hwei S Pang,Li-Ping Lin,Ju-Wen Cheng,Shih-Jung Liu,Wen-Chung Tsai

Scientific reports 10:16686 PubMed33028951

2020

Nesfatin-1 and nesfatin-1-like peptide suppress growth hormone synthesis via the AC/PKA/CREB pathway in mammalian somatotrophs.

Applications

Unspecified application

Species

Unspecified reactive species

Emilio J Vélez,Suraj Unniappan

Journal of anatomy 238:20-35 PubMed32790077

2020

Anatomical evidence of non-parasympathetic cardiac nitrergic nerve fibres in rat.

Applications

Unspecified application

Species

Unspecified reactive species

Ieva Navickaite,Neringa Pauziene,Dainius H Pauza

Cancers 12: PubMed32353988

2020

Effects of Beta-Blockers on Melanoma Microenvironment and Disease Survival in Human.

Applications

Unspecified application

Species

Unspecified reactive species

Ludovic Jean Wrobel,Angèle Gayet-Ageron,Frédérique-Anne Le Gal

Scientific reports 10:2089 PubMed32034259

2020

The oxytocin-prostaglandins pathways in the horse (Equus caballus) placenta during pregnancy, physiological parturition, and parturition with fetal membrane retention.

Applications

Unspecified application

Species

Unspecified reactive species

Anna Rapacz-Leonard,Mark Leonard,Małgorzata Chmielewska-Krzesińska,Marta Siemieniuch,Tomasz E Janowski

International journal of molecular sciences 20: PubMed31533326

2019

PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma.

Applications

Unspecified application

Species

Unspecified reactive species

Tiziana Annese,Roberto Ronca,Roberto Tamma,Arianna Giacomini,Simona Ruggieri,Elisabetta Grillo,Marco Presta,Domenico Ribatti

Medicina (Kaunas, Lithuania) 55: PubMed31426487

2019

An Insight into COPD Morphopathogenesis: Chronic Inflammation, Remodeling, and Antimicrobial Defense.

Applications

Unspecified application

Species

Unspecified reactive species

Zane Vitenberga,Māra Pilmane,Aurika Babjoniševa

JCI insight 4: PubMed30843886

2019

PTHrP targets HDAC4 and HDAC5 to repress chondrocyte hypertrophy.

Applications

Unspecified application

Species

Unspecified reactive species

Shigeki Nishimori,Forest Lai,Mieno Shiraishi,Tatsuya Kobayashi,Elena Kozhemyakina,Tso-Pang Yao,Andrew B Lassar,Henry M Kronenberg

Pathology, research and practice 215:97-105 PubMed30392917

2018

The evaluation of inflammatory, anti-inflammatory and regulatory factors contributing to the pathogenesis of COPD in airways.

Applications

Unspecified application

Species

Unspecified reactive species

Zane Vitenberga,Māra Pilmane,Aurika Babjoniševa

Aging clinical and experimental research 31:331-338 PubMed29951747

2018

Protective effect of resveratrol on methylglyoxal-induced endothelial dysfunction in aged rats.

Applications

Unspecified application

Species

Unspecified reactive species

A Tasatargil,G Tanriover,A Barutcigil,E Turkmen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com